The partnership adds Abbott’s Lingo OTC CGM to the Withings app community. It aims to empower people to gain a more actionable understanding of their metabolism by continuously tracking glucose.
In the initial phase, consumers can access glucose data by pairing the Withings app with the Apple Health Kit (iOS) and Health Connect (Android). The companies expect all consumers to have the ability to access the glucose data through the Lingo app via a direct application programming interface (API).
Withings said the partnership enables users to seamlessly track glucose data alongside their full suite of health data. Users can already monitor more than 90 biomarkers through connected devices. Integrating Abbott Lingo data within its ecosystem encourages consumers to take control of their health, the company said.
Now, users can purchase Lingo CGMs on Withings’ U.S. website, starting today. The companies announced their new partnership at CES 2025 in Las Vegas.
Abbott received FDA clearance for Lingo and its Libre Rio OTC CGMs in June 2024. Lingo is one of two OTC CGMs on the market, with Dexcom’s Stelo also an option for those seeking to monitor glucose levels. The company offers it through a variety of channels, including online at Amazon and in physical stores like Walmart and Walgreens.
Read more about Abbott and the rest of the diabetes tech industry in our free Diabetes Technology Special Report.
Visit here to purchase our Medtech Market Special Report on CGMs.
Commentary from Withings and Abbott officials
Eric Carreel, founder and president of Withings, said:
“True wellness begins with understanding every part of your health data. With Withings’ smart scales, blood-pressure monitors, and wearables, individuals can track biomarkers such as pulse wave velocity (arterial stiffness), vascular age, fat vs muscle vs visceral fat, resting heart rate, body water, bone mass, and more. Layered with insights gained from glucose data from Abbott’s Lingo, this gives a uniquely rich and holistic view of long-term well-being. Through this partnership, we’re making it easier for individuals to take charge of their health journey — with insight, awareness, and confidence.”
Olivier Ropars, division VP of Abbott’s Lingo business, said:
“Abbott has been pioneering glucose tracking for more than a decade and we are excited to bring glucose data to consumers focused on improving their overall health and wellness with the Lingo over-the-counter CGM. By bringing glucose data to the Withings community, we can help empower them to build better habits to improve their overall metabolic health. Improving metabolic health can reduce the risk of chronic conditions, including prediabetes, and understanding glucose is a powerful way to unlock insights on overall health.”
